Lion Biotechnologies Announces 5-Year Extension of National Cancer Institute CRADA for Development of Novel TIL Immuno-Oncology Therapies Read more about Lion Biotechnologies Announces 5-Year Extension of National Cancer Institute CRADA for Development of Novel TIL Immuno-Oncology Therapies
Lion Biotechnologies Enters Into Exclusive License Agreement With PolyBioCept AB and Clinical Trials Agreement With the Karolinska University Hospital Read more about Lion Biotechnologies Enters Into Exclusive License Agreement With PolyBioCept AB and Clinical Trials Agreement With the Karolinska University Hospital
Lion Biotechnologies Appoints Gregory Schiffman as Chief Financial Officer Read more about Lion Biotechnologies Appoints Gregory Schiffman as Chief Financial Officer
Lion Biotechnologies Announces Presentations at Upcoming SITC 31st Annual Meeting Read more about Lion Biotechnologies Announces Presentations at Upcoming SITC 31st Annual Meeting
Lion Biotechnologies to Host Conference Call to Discuss Third Quarter 2016 Financial and Operating Results on Friday, November 4, 2016 Read more about Lion Biotechnologies to Host Conference Call to Discuss Third Quarter 2016 Financial and Operating Results on Friday, November 4, 2016
Lion Biotechnologies Reports Third Quarter 2016 Financial Results and Provides Corporate Update Read more about Lion Biotechnologies Reports Third Quarter 2016 Financial Results and Provides Corporate Update
Lion Biotechnologies Presents Encouraging TIL Technology Data in Four Posters at 2016 SITC Annual Meeting Read more about Lion Biotechnologies Presents Encouraging TIL Technology Data in Four Posters at 2016 SITC Annual Meeting
Lion Biotechnologies to Present at the 28th Annual Piper Jaffray Healthcare Conference Read more about Lion Biotechnologies to Present at the 28th Annual Piper Jaffray Healthcare Conference
Lion Biotechnologies to Present at the 28th Annual Piper Jaffray Healthcare Conference Read more about Lion Biotechnologies to Present at the 28th Annual Piper Jaffray Healthcare Conference
Lion Biotechnologies Announces New Manufacturing Services Agreement with WuXi AppTec Read more about Lion Biotechnologies Announces New Manufacturing Services Agreement with WuXi AppTec